Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: A meta-analysis of prospective, randomized trials

Clinical Infectious Diseases

Volumn 43, Issue 4, 2006, Pages 474-484

  Safdar, Nssia ^a   Maki, Dennis G ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CIPROFLOXACIN; HEPARIN; VANCOMYCIN;

BACTERIAL COLONIZATION; BACTERIUM CULTURE; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DEVICE INFECTION; DRUG EFFICACY; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFECTION PREVENTION; LONG TERM EXPOSURE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; META ANALYSIS; MORBIDITY; MORTALITY; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW; VASCULAR ACCESS;

ADULT; ANTI-BACTERIAL AGENTS; CATHETERIZATION, CENTRAL VENOUS; CHILD; HUMANS; SEPSIS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 33746633900     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/505976     Document Type: Review

References (104)

1. Greene JN. Catheter-related complications of cancer therapy. Infect Dis Clin North Am 1996; 10:255-95.
2. Raad II, Fraschini G. Intravascular de vice-related infections in cancer patients. Cancer Treat Res 1995; 79:211-31.
3. Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices. Clin Infect Dis 2002; 34:1362-8.
4. Crnich CJ, Maki DG. The Role of intravascular devices in sepsis. Curr Infect Dis Rep 2001; 3:496-506.
5. Arnow PM, Quimosing EM, Beach M. Consequences of intravascular catheter sepsis. Clin Infect Dis 1993; 16:778-84.
6. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271:1598-601.
7. Collignon PJ. Intravascular catheter associated sepsis: a common problem: The Australian Study on Intravascular Catheter Associated Sepsis. Med J Aust 1994; 161:374-8.
8. Rello J, Ochagavia A, Sabanes E, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 2000; 162:1027-30.
9. Smith RL, Meixler SM, Simberkoff MS. Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest 1991; 100:164-7.
10. Marrie TJ, Costerton JW. Scanning and transmission electron microscopy of in situ bacterial colonization of intravenous and intra-arterial catheters. J Clin Microbiol 1984; 19:687-93.
11. Cooper GL, Schiller AL, Hopkins CC. Possible role of capillary action in pathogenesis of experimental catheter-associated dermal tunnel infections. J Clin Microbiol 1988; 26:8-12.
12. Sitges-Serra A, Linares J, Garau J. Catheter sepsis: the clue is the hub. Surgery 1985; 97:355-7.
13. Safdar N, Maki DG. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med 2004; 30:62-7.
14. Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 1991; 91:197S-205S.
15. Bjornson HS, Colley R, Bower RH, Duty VP, Schwartz-Fulton JT, Fischer JE. Association between microorganism growth at the catheter insertion site and colonization of the catheter in patients receiving total parenteral nutrition. Surgery 1982; 92:720-7.
16. Sitges-Serra A, Puig P, Linares J, et al. Hub colonization as the initial step in an outbreak of catheter-related sepsis due to coagulase negative staphylococci during parenteral nutrition. JPEN J Parenter Enteral Nutr 1984; 8:668-72.
17. Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993; 168:400-7.
18. Garland JS, Alex CP, Mueller CD, et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001; 107:1431-6.
19. Bouza E, Burillo A, Munoz P. Catheter-related infections: diagnosis and intravascular treatment. J Chemother 2001; 13(Spec 1):224-33.
20. Carratala J. Role of antibiotic prophylaxis for the prevention of intravascular catheter-related infection. Clin Microbiol Infect 2001; 7(Suppl 4):83-90.
21. Capdevila JA. Catheter-related infection: an update on diagnosis, treatment, and prevention. Int J Infect Dis 1998; 2:230-6.
22. Sohn AH, Garrett DO, Sinkowitz-Cochran RL, et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey. J Pediatr 2001; 139:821-7.
23. Salzman MB, Isenberg HD, Shapiro JF, Lipsitz PJ, Rubin LG. A prospective study of the catheter hub as the portal of entry for microorganisms causing catheter-related sepsis in neonates. J Infect Dis 1993; 167:487-90.
24. Fallal ME, Gallinaro RN, Stover BH, Wilkerson S, Goldsmith LJ. Central venous catheter bloodstream infections in the neonatal intensive care unit. J Pediatr Surg 1998; 33:1383-7.
25. Spafford PS, Sinkin RA, Cox C, Reubens L, Powell KR. Prevention of central venous catheter-related coagulase-negative staphylococcal sepsis in neonates. J Pediatr 1994; 125:259-63.
26. Clarke M. The QUORUM statement. Lancet 2000; 355:756-7.
27. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-88.
28. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22:719-48.
29. Higgins JP, Thompson SG, Decks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-60.
30. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-34.
31. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 2001; 54:1046-55.
32. Bleyer AJ, Mason L, Russell G, Raad II, Sherertz RJ. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol 2005; 26:520-4.
33. Chatzinikolaou I, Zipf TF, Hanna H, et al. Minocycline- ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer. Clin Infect Dis 2003; 36:116-9.
34. McIntyre CW, Hulme LJ, Taal M, Fluck RJ. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int 2004; 66:801-5.
35. Lambie SH, Hulme LJ, Taal M, Fluck RJ, McIntyre CW. Prospective study of gentamicin locking of tunnelled dialysis catheters: the effect on infection rates and CRP. Kidney Int 2005; 67:378.
36. Canaud B, Morena M, Leray-Moragues H. [Dialock: results of a French multicenter study]. Nephrologie 2001; 22:391-7.
37. Sodemann K, Polaschegg HD, Feldmer B. Two years' experience with Dialock and CLS (a new antimicrobial lock solution). Blood Purif 2001; 19:251-4.
38. Dogra GK, Herson H, Hutchison B, et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 2002; 13:2133-9.
39. Raad I, Buzaid A, Rhyne J, et al. Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections. Clin Infect Dis 1997; 25:149-51.
40. Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 2003; 36:1539-44.
41. Quarello F, Forneris G. Prevention of hemodialysis catheter-related bloodstream infection using an antimicrobial lock. Blood Purif 2002; 20:87-92.
42. Jurewitsch B, Lee T, Park J, Jeejeebhoy K. Taurolidine 2% as an antimicrobial lock solution for prevention of recurrent catheter-related bloodstream infections. JPEN J Parenter Enteral Nutr 1998; 22:242-4.
43. Shah CB, Mittelman MW, Costerton JW, et al. Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother 2002; 46:1674-9.
44. Guedon C, Nouvellon M, Lalaude O, Lerebours E. Efficacy of antibiotic-lock technique with teicoplanin in staphylococcus epidermidis catheter-related sepsis during long-term parenteral nutrition. JPEN J Parenter Enteral Nutr 2002; 26:109-13.
45. Dannenberg C, Bierbach U, Rothe A, Beer J, Korholz D. Ethanol-lock technique in the treatment of bloodstream infections in pediatric oncology patients with broviac catheter. J Pediatr Hematol Oncol 2003; 25:616-21.
46. Cuntz D, Michaud L, Guimber D, Husson MO, Gottrand F, Turck D. Local antibiotic lock for the treatment of infections related to central catheters in parenteral nutrition in children. JPEN J Parenter Enteral Nutr 2002; 26:104-8.
47. Boorgu R, Dubrow AJ, Levin NW, et al. Adjunctive antibiotic/anticoagulant lock therapy in the treatment of bacteremia associated with the use of a subcutaneously implanted hemodialysis access device. Asaio J 2000; 46:767-70.
48. Cowan CE. Antibiotic lock technique. J Intraven Nurs 1992; 15:283-7.
49. Flynn PM, Shenep JL, Stokes DC, Barrett FF. In situ management of confirmed central venous catheter-related bacteremia. Pediatr Infect Dis J 1987; 6:729-34.
50. Guillet P, LaScola B, Bagarry-Liegey D, et al. [Clinical pilot study on repeated use of heparin, vancomycin, colimycine locked flush solution for central intravenous implanted catheter in oncology]. Pathol Biol (Paris) 1997; 45:506-13.
51. Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J Antimicrob Chemother 2005; 55:90-4.
52. Benoit JL, Carandang G, Sitrin M, Arnow PM. Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin Infect Dis 1995; 21:1286-8.
53. Johnson DC, Johnson FL, Goldman S. Preliminary results treating persistent central venous catheter infections with the antibiotic lock technique in pediatric patients. Pediatr Infect Dis J 1994; 13:930-1.
54. Capdevila JA, Segarra A, Planes AM, et al. Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol Dial Transplant 1993; 8:231-4.
55. Ruiz-Valverde MP, Barbera JR, Segarra A, Capdevila JA, Evangelista A, Piera L. Successful treatment of catheter-related sepsis and extraluminal catheter thrombosis with vancomycin and fraxiparin without catheter removal. Nephron 1997; 75:354-5.
56. Messing B, Peitra-Cohen S, Debure A, Beliah M, Bernier JJ. Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Parenter Enteral Nutr 1988; 12:185-9.
57. Bregenzer T, Widmer AF. Bloodstream infection from a Port-A-Cath: successful treatment with the antibiotic lock technique. Infect Control Hosp Epidemiol 1996; 17:772.
58. Viale P, Pagani L, Petrosillo N, et al. Antibiotic lock-technique for the treatment of catheter-related bloodstream infections. J Chemother 2003; 15:152-6.
59. Krishnasami Z, Carlton D, Bimbo L, et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int 2002; 61:1136-42.
60. Andris DA, Krzywda EA, Edmiston CE, Krepel CJ, Gohr CM. Elimination of intraluminal colonization by antibiotic lock in silicone vascular catheters. Nutrition 1998; 14:427-32.
61. Haimi-Cohen Y, Husain N, Meenan J, Karayalcin G, Lehrer M, Rubin LG. Vancomycin and ceftazidime bioactivities persist for at least 2 weeks in the lumen in ports: simplifying treatment of port-associated bloodstream infections by using the antibiotic lock technique. Antimicrob Agents Chemother 2001; 45:1565-7.
62. Douard MC, Arlet G, Leverger G, et al. Quantitative blood cultures for diagnosis and management of catheter-related sepsis in pediatrie hematology and oncology patients. Intensive Care Med 1991; 17:30-5.
63. Williams N, Carlson GL, Scott NA, Irving MH. Incidence and management of catheter-related sepsis in patients receiving home parenteral nutrition. Br J Surg 1994; 81:392-4.
64. Arnow PM, Kushner R. Malassezia furfur catheter infection cured with antibiotic lock therapy. Am J Med 1991; 90:128-30.
65. Krzywda EA, Andris DA, Edmiston CE Jr, Quebbeman EJ. Treatment of Hickman catheter sepsis using antibiotic lock technique. Infect Control Hosp Epidemiol 1995; 16:596-8.
66. Ocete E, Ruiz-Extremera A, Goicoechea A, et al. Low-dosage prophylactic vancomycin in central-venous catheters for neonates. Early Hum Dev 1998;53(Suppl):S181-6.
67. Santarpia L, Pasanisi F, Alfonsi L, et al. Prevention and treatment of implanted central venous catheter (CVC)- related sepsis: a report after six years of home parenteral nutrition (HPN). Clin Nutr 2002; 21:207-11.
68. Fourcade J, Mallaval FO, Raffenot D, Mercier D, Maret J, Morel B. [Value of an antibiotic lock for the prevention of bacteremia recurrence from central catheters in chronic hemodialysis]. Nephrologic 2001; 22:457-8,
69. Rubie H, Juricic M, Claeyssens S, et al. Morbidity using subcutaneous ports and efficacy of vancomycin flushing in cancer. Arch Dis Child 1995; 72:325-9.
70. Graham A, Finer N. Vancomycin flush technique to prevent coagulase-negative staphylococcus infection in VLBW infants: a prospective placebo- controlled randomized trial. In: Program and abstracts of the Proceedings of the Annual Meeting of the Society of Pediatric Research (Baltimore, MD). 2002.
71. Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis 2004; 44:779-91.
72. Bagnall-Reeb H. Evidence for the use of the antibiotic lock technique. J Infus Nurs 2004; 27:118-22.
73. Carratala J. The antibiotic-lock technique for therapy of 'highly needed' infected catheters. Clin Microbiol Infect 2002; 8:282-9.
74. Bouza E, Burillo A, Munoz P. Catheter-related infections: diagnosis and intravascular treatment. Clin Microbiol Infect 2002; 8:265-74.
75. Salzman MB, Rubin LG. Intravenous catheter-related infections. Adv Pediatr Infect Dis 1995; 10:337-68.
76. Bestul MB, Vandenbussche HL. Antibiotic lock technique: review of the literature. Pharmacotherapy 2005; 25:211-27.
77. Baier RJ, Bocchini JA Jr, Brown EG. Selective use of vancomycin to prevent coagulase-negative staphylococcal nosocomial bacteremia in high risk very low birth weight infants. Pediatr Infect Dis J 1998; 17:179-83.
78. Cooke RW, Nycyk JA, Okuonghuae H, Shah V, Damjanovic V, Hart CA. Low-dose vancomycin prophylaxis reduces coagulase-negative staphylococcal bacteraemia in very low birthweight infants. J Hosp Infect 1997; 37:297-303.
79. Moller JC, Nachtrodt G, Richter A, Tegtmeyer FK. Prophylactic vancomycin to prevent staphylococcal septicaemia in very-low-birth-weight infants. Lancet 1992; 340:424.
80. Moller JC, Nachtrodt G, Tegtmeyer FK, Richter A, Gortner L. Prophylactic low-dose vancomycin treatment in very-low-birth-weight infants. Dev Pharmacol Ther 1992; 19:178-82.
81. Moller JC, Nelskamp I, Jensen R, et al. Comparison of vancomycin and teicoplanin for prophylaxis of sepsis with coagulase negative staphylococci (CONS) in very low birth weight (VLBW) infants. J Perinat Med 1997; 25:361-7.
82. Vassilomanolakis M, Plataniotis G, Koumakis G, et al. Central venous catheter-related infections after bone marrow transplantation in patients with malignancies: a prospective study with short-course vancomycin prophylaxis. Bone Marrow Transplant 1995; 15:77-80.
83. Kacica MA, Morgan MJ, Ochoa L, Sandler R, Lepow ML, Venezia RA. Prevention of gram-positive sepsis in neonates weighing less than 1500 grams. J Pediatr 1994; 125:253-8.
84. Ranson MR, Oppenheim BA, Jackson A, Kamthan AG, Scarffe JH. Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J Hosp Infect 1990; 15:95-102.
85. Garland JS, Alex CP, Henrickson KJ, McAuliffe TL, Maki DG. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial. Pediatrics 2005; 116:e198-205.
86. Carratala J, Niubo J, Fernandez-Sevilla A, et al. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother 1999; 43:2200-4.
87. Barriga FJ, Varas M, Potin M, et al. Efficacy of a vancomycin solution to prevent bacteremia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. Med Pediatr Oncol 1997; 28:196-200.
88. Schwartz C, Henrickson KJ, Roghmann K, Powell K. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol 1990; 8:1591-7.
89. Rackoff WR, Weiman M, Jakobowski D, et al. A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children. J Pediatr 1995; 127:147-51.
90. Henrickson KJ, Axtell RA, Hoover SM, et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/ heparin flush solution: A randomized, multicenter, double-blind trial. J Clin Oncol 2000; 18:1269-78.
91. Daghistani D, Horn M, Rodriguez Z, Schoenike S, Toledano S. Prevention of indwelling central venous catheter sepsis. Med Pediatr Oncol 1996; 26:405-8.
92. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000; 132:391-402.
93. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 51:1-29.
94. van de Wetering MD, van Woensel JB, Kremer LC, Caron HN. Prophylactic antibiotics for preventing early gram-positive central venous catheter infections in oncology patients, a Cochrane systematic review. Cancer Treat Rev 2005; 31:186-96.
95. Maki DG, Crnich CJ, Safdar NAI. Successful use of a 25% alcohol lock solution for prevention of recurrent CVC-related bloodstream infection in a patient on home TNA [abstract K-671]. In: Program and abstracts of the Forty-second Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego, CA). 2002.
96. Betjes MG, van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 2004; 19:1546-51.
97. Crnich CJ, Halfmann JA, Crone WC, Maki DG. The effects of prolonged ethanol exposure on the mechanical properties of polyurethane and silicone catheters used for intravascular access. Infect Control Hosp Epidemiol 2005; 26:708-14.
98. Tan L, Hawk JC 3rd, Sterling ML. Report of the Council on Scientific Affairs: preventing needlestick injuries in health care settings. Arch Intern Med 2001; 161:929-36.
99. Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998; 47:1-33.
100. Salgado CD, Chinnes L, Cantey JR. Significantly increased rate of catheter-related bloodstream infections associated with use of a needleless valve system in a long-term acute care hospital. In: Program and abstracts for the Society for Healthcare Epidemiology of America (Chicago, IL). 2006.
101. Maragakis LL, Bradley KL, Song X, et al. Increased catheter-related bloodstream infection rates after the introduction of a new mechanical valve intravenous access port. Infect Control Hosp Epidemiol 2006; 27:67-70.
102. McDonald LC, Banerjee SN, Jarvis WR. Line-associated bloodstream infections in pediatric intensive-care-unit patients associated with a needleless device and intermittent intravenous therapy. Infect Control Hosp Epidemiol 1998; 19:772-7.
103. Danzig LE, Short LJ, Collins K, et al. Bloodstream infections associated with a needleless intravenous infusion system in patients receiving home infusion therapy. JAMA 1995; 273:1862-4.
104. Do AN, Ray BJ, Banerjee SN, et al. Bloodstream infection associated with needleless device use and the importance of infection-control practices in the home health care setting. J Infect Dis 1999; 179:442-8.